AmplideX® PCR/CE SMN1/2 Plus Kit

Copy number variations in SMN1 and SMN2 are, respectively, associated with the onset and severity of spinal muscular atrophy (SMA), a debilitating and life-threatening illness of the central nervous system. Recent studies have demonstrated that transmission risk and disease severity may be impacted by the presence of additional variants, such as SMN1 gene duplication events and disease modifier in SMN2.

The AmplideX® PCR/CE SMN1/2 Plus Kit* revolutionizes the analysis of these two genes by delivering comprehensive results in less than four hours. Powered by AmplideX technology, the assay accurately quantifies SMN1 and SMN2 exon 7 copy number and also detects SMN1 gene duplication and SMN2 disease modifier variants – all from a single reaction. The assay shares a common workflow with other assays in the AmplideX product portfolio and is optimized for use on widely established laboratory equipment.

Features & Benefits

Reduced Complexity
  • Similar workflow to AmplideX PCR/CE FMR1*† kit eases implementation and training
  • Multiplexed, scalable design allows analysis of single-nucleotide variants, small indels, and copy-number changes from a single PCR reaction
  • Assay-specific software automates variant calls and streamlines data analysis
Optimized Workflow
  • DNA-to-data in less than four hours with only 60 minutes of hands-on-time
  • Optimized for use on commonly installed CE equipment
  • Fully-kitted solution sourced from a single vendor
Quality Results
  • Ability to differentiate between 0, 1, 2, 3 and ≥4 copies for both SMN1 and SMN2
  • Automated variant and copy-number genotyping
  • Accuracy demonstrated through comparisons with multiple orthogonal methods

Download Brochure

 

 

 

*For Research Use Only. Not for use in Diagnostic procedures.
CE-IVD for US Export Only.

Analytical Characteristics

  • Automated reporting of SMN1/2 copy number and variant detection via AmplideX Reporter Software (Figure 1)
  • DNA to data in less than four hours – all from a single PCR reaction (Figure 2)
  • Excellent concordance of SMN1 and SMN2 copy number results to sites’ in-house methods for over 500 replicates (Figure 3)
  • High assay specificity permits detection of SMN1–SMN2 hybrid peaks, including those resulting from gene conversion events (Figure 4)
  • 100% agreement between Sanger sequencing and PCR/CE SMN1/2 Plus Kit for detection of SMN1 gene duplication and SMN2 disease modifier variants (Figure 5).

 

Figure 1. Example Electropherogram Output – AmplideX PCR/CE SMN1/2 Plus Kit

 

Figure 2. AmplideX PCR/CE SMN1/2 Plus Kit Testing Workflow

 

Figure 3. Reproducibility of SMN1 and SMN2 copy number reporting across sites for over 500 replicates.

Figure 4. Detection and differentiation of SMN1 and SMN2 hybrid peaks.


Figure 5.
Agreement between AmplideX PCR/CE SMN1/2 Plus Kit and Sanger sequencing for SMN1 gene duplication and SMN2 disease modifier variants

Additional Resources

Videos

View poster

 

View poster

 

From Two Days to Four Hours: How the AmplideX PCR/CE SMN1/2 Plus Kit Provides SMN1 and SMN2 Copy Number Information and More…

 

Posters

A Rapid Diagnostic and Screening System for Spinal Muscular Atrophy that Reports Copy Number Changes, Single Nucleotide Variants and Small Indels
View Full Poster

Ordering Information

Product Name Number of Reactions Catalog Number
AmplideX® PCR/CE SMN1/2 Plus Kit (RUO) 50 A00050
AmplideX® PCR/CE SMN1/2 Plus Kit (RUO) 100 A00054

T 1-877-777-1874; 512-681-5200
F 512-681-5202
E orders@asuragen.com

AmplideX® PCR/CE SMN1/2 Plus Kit

Copy number variations in SMN1 and SMN2 are, respectively, associated with the onset and severity of spinal muscular atrophy (SMA), a debilitating and life-threatening illness of the central nervous system. Recent studies have demonstrated that transmission risk and disease severity may be impacted by the presence of additional variants, such as SMN1 gene duplication events and disease modifier in SMN2.

The AmplideX® PCR/CE SMN1/2 Plus Kit* revolutionizes the analysis of these two genes by delivering comprehensive results in less than four hours. Powered by AmplideX technology, the assay accurately quantifies SMN1 and SMN2 exon 7 copy number and also detects SMN1 gene duplication and SMN2 disease modifier variants – all from a single reaction. The assay shares a common workflow with other assays in the AmplideX product portfolio and is optimized for use on widely established laboratory equipment.

Features & Benefits

Copy number variations in SMN1 and SMN2 are, respectively, associated with the onset and severity of spinal muscular atrophy (SMA), a debilitating and life-threatening illness of the central nervous system. Recent studies have demonstrated that transmission risk and disease severity may be impacted by the presence of additional variants, such as SMN1 gene duplication events and disease modifier in SMN2.

The AmplideX® PCR/CE SMN1/2 Plus Kit* revolutionizes the analysis of these two genes by delivering comprehensive results in less than four hours. Powered by AmplideX technology, the assay accurately quantifies SMN1 and SMN2 exon 7 copy number and also detects SMN1 gene duplication and SMN2 disease modifier variants – all from a single reaction. The assay shares a common workflow with other assays in the AmplideX product portfolio and is optimized for use on widely established laboratory equipment.

Analytical Characteristics

 

 

Additional Resources

 

 

Ordering Information

Product Name Number of Reactions Catalog Number
AmplideX® PCR/CE SMN1/2 Plus Kit (RUO) 50 A00050
AmplideX® PCR/CE SMN1/2 Plus Kit (RUO) 100 A00054

T 1-877-777-1874; 512-681-5200
F 512-681-5202
E orders@asuragen.com

Back To
Top